Bronchiectasis (non-CF) — management & exacerbation
bronchiectasis · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Permanent abnormal bronchial dilatation with a chronic cough, daily sputum, and recurrent infective exacerbations. Management rests on airway clearance, treating exacerbations with longer antibiotic courses, and addressing the underlying cause and chronic airway infection (notably Pseudomonas aeruginosa).
Red flags
- Massive haemoptysis (-> dedicated pathway; consider bronchial artery embolisation)
- New or persistent Pseudomonas / NTM isolation
- Rapidly declining lung function or frequent hospitalisations
- Weight loss / systemic deterioration (exclude NTM, malignancy, immunodeficiency)
- Respiratory failure during severe exacerbation
Assessment
Differential diagnosis
- COPD
- Asthma / ABPA
- Chronic infection: post-TB, non-tuberculous mycobacteria
- Cystic fibrosis (adult presentation)
- Primary ciliary dyskinesia
- Immunodeficiency (hypogammaglobulinaemia)
- Connective-tissue disease / rheumatoid-associated
- Chronic aspiration
Investigations
- High-resolution CT thorax — diagnostic (bronchial dilatation > adjacent artery, lack of tapering, visible airways at periphery)
- Sputum culture incl. Pseudomonas, other Gram-negatives, and mycobacteria (AFB + NTM culture)
- Spirometry (often obstructive pattern)
- Aetiology screen: serum immunoglobulins (IgG/A/M), specific antibody responses, Aspergillus IgE/IgG + total IgE (ABPA), rheumatoid factor/anti-CCP, HIV, alpha-1 antitrypsin if indicated; sweat test/CFTR if CF suspected
- FBC, CRP; baseline oxygen saturation
- Baseline ECG/QTc and audiometry before long-term macrolide; EXCLUDE NTM before macrolide monotherapy
Management
- Confirm with HRCT and identify a treatable cause (immunodeficiency, ABPA, NTM, CF, reflux/aspiration)
- Teach daily airway clearance techniques (active cycle of breathing, oscillatory PEP device) via respiratory physiotherapy — cornerstone of care
- Consider nebulised mucoactive/hypertonic saline if symptoms persist despite clearance
- Treat exacerbations (increased cough/sputum volume/purulence/breathlessness) with a targeted 14-day antibiotic course guided by prior sputum microbiology
- Cover Pseudomonas with ciprofloxacin if known colonisation; attempt eradication on first Pseudomonas isolation
- For frequent exacerbators (>=3/yr), consider long-term macrolide (azithromycin) after excluding NTM and checking QTc/hearing
- Pulmonary rehabilitation, vaccination (influenza/pneumococcal), smoking cessation, optimise nutrition
- Refer to respiratory/specialist bronchiectasis service for recurrent exacerbations, Pseudomonas, haemoptysis, or diagnostic uncertainty
Drugs & doses
Exacerbation (no Pseudomonas): amoxicillin 500 mg PO TDS, or doxycycline 100 mg PO OD (200 mg day 1), or co-amoxiclav 625 mg PO TDS — 14-day course, adjust to sputum sensitivities [verify local policy]
Exacerbation (Pseudomonas-colonised, oral): ciprofloxacin 500-750 mg PO BD for 14 days [verify local dose]
Severe/IV Pseudomonas exacerbation: ceftazidime 2 g IV TDS or piperacillin-tazobactam 4.5 g IV TDS +/- aminoglycoside for 14 days [verify local policy]
Pseudomonas eradication (first isolation): oral ciprofloxacin +/- inhaled colistin or tobramycin per specialist protocol [verify local protocol]
Long-term prophylaxis: azithromycin 250-500 mg PO three times weekly (exclude NTM, baseline ECG/QTc + audiometry) [verify local dose]
Nebulised hypertonic saline 3-7% BD as mucoactive adjunct (pre-treat with bronchodilator) [verify local dose]
Disposition
Mostly outpatient. Admit for severe exacerbation, IV antibiotics (Pseudomonas/sepsis), haemoptysis, or respiratory failure. Specialist respiratory follow-up for chronic infection or frequent exacerbations.
Complications & pitfalls
- Recurrent/chronic bacterial infection and progressive airway destruction
- Haemoptysis (can be massive)
- Chronic respiratory failure, cor pulmonale
- Pseudomonas and NTM colonisation
- Secondary amyloidosis (chronic suppuration)
- Reduced quality of life, frequent admissions
Exam pearls
- Airway clearance taught by a respiratory physiotherapist is a strong recommendation for all patients (ERS 2025 / BTS 2019 bronchiectasis guidelines).
- Exacerbations are treated for 14 days — longer than an ordinary chest infection.
- Consider long-term azithromycin after >=3 exacerbations/year, but ALWAYS exclude NTM first (macrolide monotherapy risks resistance) and check QTc + hearing.
- Always attempt eradication at the FIRST isolation of Pseudomonas aeruginosa — chronic colonisation worsens prognosis.
- Hunt for a treatable cause in every patient: immunoglobulin deficiency, ABPA, NTM, and CF change management.
- Base antibiotic choice on the patient's own recent sputum sensitivities wherever possible.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.